Compare FGNX & BHST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | FGNX | BHST |
|---|---|---|
| Founded | 1932 | 2007 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 44.1M | 41.3M |
| IPO Year | 2014 | 2017 |
| Metric | FGNX | BHST |
|---|---|---|
| Price | $7.61 | $1.62 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $35.00 | $10.00 |
| AVG Volume (30 Days) | ★ 108.6K | 30.6K |
| Earning Date | 05-19-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $32,023,000.00 | N/A |
| Revenue This Year | $650.31 | $146.27 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 20.70 | N/A |
| 52 Week Low | $1.59 | $1.55 |
| 52 Week High | $9.35 | $12.80 |
| Indicator | FGNX | BHST |
|---|---|---|
| Relative Strength Index (RSI) | 49.10 | 27.74 |
| Support Level | $5.64 | N/A |
| Resistance Level | $7.71 | $2.05 |
| Average True Range (ATR) | 0.64 | 0.10 |
| MACD | -0.15 | -0.01 |
| Stochastic Oscillator | 53.68 | 12.02 |
FG Nexus Inc operates through two primary segments: Digital Assets and Merchant Banking, with Digital Assets contributing the majority of revenue. The Company functions as a digital asset treasury, mainly holding Ethereum (ETH) and exploring opportunities in the tokenization of real-world assets, leveraging ETH as the foundation for digital finance, stablecoins, DeFi, and tokenized assets. The Merchant Banking segment offers strategic, administrative, and regulatory support to newly formed SPACs through the Company's SPAC platform.
BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. The Company has two operating segments or business units: the Products business unit and the CDMO Services business unit. In identifying these operating segments, management generally follows the Company's service lines representing its main products and services. The Products Business Unit - Nutraceuticals: Research, development, manufacturing, marketing and sales of science-based health and wellness nutraceutical solutions which are manufactured and sold as dietary supplements, functional food and beverages. The CDMO Services Business Unit - comprising a Contract Development and Manufacturing Operation that offers pharmaceuticals, cosmeceuticals, nutraceuticals, and nutritions.